Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoko Okiyama

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Journal of Clinical Medicine|April 30, 2021
Clinical Features and Cutaneous Manifestations of Juvenile and Adult Patients of Dermatomyositis Associated with Myositis-Specific AutoantibodiesNaoko Okiyama
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|March 14, 2015
[Mucocutaneous diseases and murine models with death of keratinocytes induced by lichenoid tissue reaction/interface dermatitis]Naoko Okiyama
Allergology International : Official Journal of the Japanese Society of Allergology|February 1, 2022
Immune-related adverse events in various organs caused by immune checkpoint inhibitorsNaoko Okiyama, Ryota Tanaka
F1000Research|December 12, 2019
Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodiesNaoko Okiyama, Manabu Fujimoto
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|June 13, 2017
Varied immuno-related adverse events induced by immune-check point inhibitors - Nivolumab-associated psoriasiform dermatitis related with increased serum level of interleukin-6Naoko Okiyama, Ryota Tanaka
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 1, 2008
[Recent research developments in polymyositis/dermatomyositis]Naoko Okiyama, Hitoshi Kohsaka
Journal of Dermatological Science|March 28, 2015
Clinical perspectives and murine models of lichenoid tissue reaction/interface dermatitisNaoko Okiyama, Manabu Fujimoto
Journal of Autoimmunity|July 23, 2014
Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytesNaoko Okiyama, Stephen I Katz
The Journal of Dermatology|February 7, 2024
Murine models of idiopathic inflammatory myopathiesNaoko Okiyama, Risa Konishi, Yuki Ichimura
Immunological Medicine|October 25, 2022
Murine models of idiopathic inflammatory myopathyRisa Konishi, Yuki Ichimura, Naoko Okiyama
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Journal of Clinical Medicine|April 30, 2021
Clinical Features and Cutaneous Manifestations of Juvenile and Adult Patients of Dermatomyositis Associated with Myositis-Specific AutoantibodiesNaoko Okiyama
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|March 14, 2015
[Mucocutaneous diseases and murine models with death of keratinocytes induced by lichenoid tissue reaction/interface dermatitis]Naoko Okiyama
Allergology International : Official Journal of the Japanese Society of Allergology|February 1, 2022
Immune-related adverse events in various organs caused by immune checkpoint inhibitorsNaoko Okiyama, Ryota Tanaka
F1000Research|December 12, 2019
Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodiesNaoko Okiyama, Manabu Fujimoto
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|June 13, 2017
Varied immuno-related adverse events induced by immune-check point inhibitors - Nivolumab-associated psoriasiform dermatitis related with increased serum level of interleukin-6Naoko Okiyama, Ryota Tanaka
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 1, 2008
[Recent research developments in polymyositis/dermatomyositis]Naoko Okiyama, Hitoshi Kohsaka
Journal of Dermatological Science|March 28, 2015
Clinical perspectives and murine models of lichenoid tissue reaction/interface dermatitisNaoko Okiyama, Manabu Fujimoto
Journal of Autoimmunity|July 23, 2014
Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytesNaoko Okiyama, Stephen I Katz
The Journal of Dermatology|February 7, 2024
Murine models of idiopathic inflammatory myopathiesNaoko Okiyama, Risa Konishi, Yuki Ichimura
Immunological Medicine|October 25, 2022
Murine models of idiopathic inflammatory myopathyRisa Konishi, Yuki Ichimura, Naoko Okiyama
Pageof 10